← 返回前沿论文

人胃肠道癌症中新抗原反应性 T 细胞的转录组图谱

英文原题:Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers.

查看英文原题

Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers.

PubMed 2022/04/11(内容时间) Cancer Cell Q1 · IF 56.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

肿瘤浸润性新抗原反应性 T 细胞能够介导转移性胃肠道肿瘤的消退,但目前对其特征仍了解不足。

中文摘要

肿瘤浸润性新抗原反应性T细胞能够介导转移性胃肠道肿瘤的消退,但目前对其特征仍认识不足。我们对胆管癌和胰腺癌患者的TIL(肿瘤浸润淋巴细胞)进行了针对个体化新抗原的免疫筛选,并结合单细胞RNA测序,以描绘新抗原反应性T细胞的转录组图谱。我们发现,与非新抗原反应性旁观者细胞相比,大多数新抗原反应性CD8+ T细胞呈现耗竭状态,并具有显著的CXCL13和GZMA共表达。来自一名胆管癌患者的大多数新抗原反应性CD4+ T细胞也表现出耗竭表型,但伴有HOPX或ADGRG1过表达,同时缺乏IL7R表达。因此,浸润胃肠道肿瘤的新抗原反应性T细胞具有独特的转录组特征,这可能为利用这些细胞进行治疗提供新的机会。

展开英文摘要原文

Tumor-infiltrating neoantigen-reactive T cells can mediate regression of metastatic gastrointestinal cancers yet remain poorly characterized. We performed immunological screening against personalized neoantigens in combination with single-cell RNA sequencing on tumor-infiltrating lymphocytes from bile duct and pancreatic cancer patients to characterize the transcriptomic landscape of neoantigen-reactive T cells. We found that most neoantigen-reactive CD8 + T cells displayed an exhausted state with significant CXCL13 and GZMA co-expression compared with non-neoantigen-reactive bystander cells. Most neoantigen-reactive CD4 + T cells from a patient with bile duct cancer also exhibited an exhausted phenotype but with overexpression of HOPX or ADGRG1 while lacking IL7R expression. Thus, neoantigen-reactive T cells infiltrating gastrointestinal cancers harbor distinct transcriptomic signatures, which may provide new opportunities for harnessing these cells for therapy.

论文信息

作者
Zheng C、Fass JN、Shih YP、Gunderson AJ、Sanjuan Silva N、Huang H、Bernard BM、Rajamanickam V
第一作者单位
Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR 97213, USA. Electronic address: chunhong.zheng@providence.org.Chile
通讯作者单位
Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR 97213, USA. Electronic address: eric.tran@providence.org.Chile
期刊
Cancer cell2022 Apr 11
原文标识
PubMed 35413272 · DOI 10.1016/j.ccell.2022.03.005